Latest market price
25.76
+1.24+5.06%
News
Up 5.1% — Zacks.com featured highlights include Healthcare Services, CarMax, Hasbro, FormFactor and MaxLinear (Yahoo).
Medium confidence
TA
Loading chart...
Snapshot
| Index | — | P/E | 17.29 | EPS (ttm) | 1.49 | Insider Own | 1.50% | Shs Outstand | 67.43M | Perf Week | 2.55% |
| Market Cap | 1.74B | Forward P/E | 20.54 | EPS next Y | 1.25 | Insider Trans | -3.35% | Shs Float | 66.65M | Perf Month | 23.43% |
| Enterprise Value | 1.54B | PEG | 4.38 | EPS next Q | 0.27 | Short Float | 4.08% | Perf Quarter | 11.27% | ||
| Income | 105.00M | P/S | 0.92 | EPS this Y | 66.78% | Short Ratio | 3.74 | Perf Half Y | 22.03% | ||
| Sales | 1.88B | P/B | 3.27 | EPS next Y | -6.21% | ROA | 12.33% | Short Interest | 2.72M | Perf YTD | 34.73% |
| Book/sh | 7.87 | P/C | 8.51 | EPS next 5Y | 3.95% | ROE | 20.22% | 52W High | 25.79 -0.12% | Perf Year | 40.69% |
| Cash/sh | 3.03 | P/FCF | 15.94 | EPS past 3/5Y | 20.76% -9.31% | ROIC | 14.31% | 52W Low | 16.78 53.52% | Perf 3Y | 165.02% |
| Dividend Est. | — | EV/EBITDA | 11.52 | Sales past 3/5Y | 2.82% 0.86% | Gross Margin | 16.34% | Volatility | 3.20% 3.50% | Perf 5Y | 29.19% |
| Dividend TTM | — | EV/Sales | 0.82 | EPS Y/Y TTM | 181.13% | Oper. Margin | 6.04% | ATR (14) | 0.83 | Perf 10Y | -29.54% |
| Dividend Ex-Date | Nov 17, 2022 | Quick Ratio | 2.82 | Sales Y/Y TTM | 4.04% | Profit Margin | 5.58% | RSI (14) | 73.36 | Recom | 2.73 |
| Dividend Gr. 3/5Y | 2.46% 2.53% | Current Ratio | 2.82 | EPS Q/Q | 56.52% | SMA20 | 14.19% | Beta | 0.88 | Target Price | 27.33 |
| Payout | 0.00% | Debt/Eq | 0.02 | Sales Q/Q | 3.45% | SMA50 | 16.91% | Rel Volume | 0.91 | Prev Close | 24.52 |
| Employees | 36,000 | LT Debt/Eq | 0.02 | Earnings | Feb 10 | SMA200 | 20.17% | Avg Volume | 733.06K | Price | 25.76 |
| IPO Date | Nov 29, 1983 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 50.91% -0.25% | Net Debt/EBITDA | -1.44 | Volume | 670,122 | Change | 5.06% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-08-26 | Reiterated | Robert W. Baird | $26 → $24 | |
| Aug-19-26 | Initiated | Oppenheimer | Outperform | $28 |
| Jul-08-26 | Reiterated | UBS | Buy | $27 → $30 |
| Apr-23-26 | Reiterated | UBS | Buy | $25 → $27 |
| Apr-23-26 | Reiterated | BMO Capital | Market Perform | $22 → $24 |
| Apr-23-26 | Reiterated | RBC Capital | Sector Perform | $20 → $24 |
| Feb-12-26 | Reiterated | UBS | Buy | $22 → $25 |
| Feb-12-26 | Reiterated | BMO Capital | $20 → $22 | |
| Feb-12-26 | Reiterated | Robert W. Baird | $20 → $23 | |
| Oct-28-25 | Reiterated | UBS | Buy | $22 |
Latest News· Times ET
Nov-02-26
Nov-02-2603:49AM
Oct-30-26
Oct-28-26
Oct-26-26
Oct-26-2609:19PM
Oct-23-26
11:01AM
10:41AM
Oct-22-26
Oct-21-26
12:38PM
11:05AM
09:16AM
Company
Healthcare Services Group, Inc., established in 1976 and based in Bensalem, Pennsylvania, provides outsourced management and operational services to healthcare and senior living facilities nationwide. The company supports departments such as housekeeping, laundry, facility maintenance, and dietary services for clients including nursing homes, retirement complexes, rehabilitation centers, and hospitals. Its Housekeeping division handles the cleaning, disinfection, and sanitization of client premises, alongside the laundering and processing of various linens. The Dietary division manages food procurement, meal preparation, and offers professional dietitian services for menu development, in addition to on-site management and clinical consulting. By December 31, 2021, the firm was serving approximately 3,000 facilities across the U.S.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,881 | 1,837 | 1,716 | 1,671 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,573 | 1,598 | 1,488 | 1,457 | — | — | — | — | — | |
| Gross Profit | 307 | 239 | 228 | 215 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 194 | 191 | 175 | 160 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Operating Income | 114 | 49 | 53 | 55 | — | — | — | — | — | |
| Interest Expense | 0 | 2 | 6 | 8 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 15 | 21 | 6 | 6 | — | — | — | — | — | |
| Net Income Before Taxes | 129 | 68 | 53 | 53 | — | — | — | — | — | |
| Income Taxes | 22 | 9 | 13 | 15 | — | — | — | — | — | |
| Consolidated Net Income | 105 | 59 | 39 | 38 | — | — | — | — | — | |
| Net Income From Continuing Operations | 105 | 59 | 39 | 38 | — | — | — | — | — | |
| Net Income | 105 | 59 | 39 | 38 | — | — | — | — | — | |
| EPS (Recurring) | 1.51 | 0.82 | 0.54 | 0.52 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.51 | 0.82 | 0.54 | 0.52 | — | — | — | — | — | |
| EPS (Diluted) | 1.49 | 0.81 | 0.53 | 0.52 | — | — | — | — | — | |
| EBITDA | 134 | 86 | 74 | 75 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 17.29 | 23.60 | 21.92 | 19.94 | — | — | — | — | — | |
| Price To Sales Ratio | 0.93 | 0.75 | 0.50 | 0.46 | — | — | — | — | — | |
| Gross Margin | 16.32 | 13.01 | 13.29 | 12.87 | — | — | — | — | — | |
| Operating Margin | 6.06 | 2.67 | 3.09 | 3.29 | — | — | — | — | — | |
| Net Margin | 5.58 | 3.21 | 2.27 | 2.27 | — | — | — | — | — | |
| Shares Outstanding | 68 | 72 | 74 | 74 | — | — | — | — | — | |
| Market Capitalization | 1,752 | 1,377 | 860 | 767 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Bundick Jason J | EVP/Gen. Counsel/Corp. Secty. | Oct 26 '26 | Sale | 25.11 | 18,239 | 457,981 | 17,125 | Oct 27 |
| Kush Andrew | EVP & Chief Operating Officer | Aug 04 '26 | Sale | 23.24 | 15,598 | 362,498 | 22,741 | Aug 05 |
| Singh Vikas | EVP & Chief Financial Officer | May 27 '26 | Option Exercise | 0.00 | 3,137 | 0 | 12,277 | May 29 |
| Brophy Andrew M | SVP & Chief Accounting Officer | Feb 26 '26 | Sale | 21.75 | 2,490 | 54,158 | 15,735 | Feb 26 |
| WAHL Theodore | President & CEO | Feb 24 '26 | Option Exercise | 0.00 | 85,789 | 0 | 563,218 | Feb 26 |
| Kush Andrew | EVP & Chief Operating Officer | Feb 24 '26 | Option Exercise | 0.00 | 17,034 | 0 | 43,692 | Feb 26 |
| Orr Patrick J | EVP & Chief Revenue Officer | Feb 24 '26 | Option Exercise | 0.00 | 12,883 | 0 | 11,466 | Feb 26 |
| SHEA JOHN CHRISTOPHER | EVP & Chief Admin. Officer | Feb 24 '26 | Option Exercise | 0.00 | 17,034 | 0 | 44,452 | Feb 26 |
| Bundick Jason J | EVP/Gen. Counsel/Corp. Secty. | Feb 24 '26 | Option Exercise | 0.00 | 13,017 | 0 | 39,455 | Feb 26 |
| Orr Patrick J | EVP & Chief Revenue Officer | Feb 18 '26 | Sale | 20.53 | 90,115 | 1,850,405 | 0 | Feb 20 |
| Orr Patrick J | EVP & Chief Revenue Officer | Feb 18 '26 | Option Exercise | 14.62 | 45,500 | 665,346 | 90,115 | Feb 19 |
| SHEA JOHN CHRISTOPHER | EVP & Chief Admin. Officer | Feb 18 '26 | Option Exercise | 17.05 | 38,857 | 662,674 | 68,149 | Feb 19 |
| SHEA JOHN CHRISTOPHER | EVP & Chief Admin. Officer | Feb 18 '26 | Sale | 20.41 | 54,357 | 1,109,189 | 29,292 | Feb 19 |
| SHEA JOHN CHRISTOPHER | EVP & Chief Admin. Officer | Jan 04 '26 | Option Exercise | 0.00 | 5,319 | 0 | 40,440 | Jan 06 |
| Brophy Andrew M | SVP & Chief Accounting Officer | Jan 04 '26 | Option Exercise | 0.00 | 695 | 0 | 19,206 | Jan 06 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.